3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

| More on:
drug capsule opening up to reveal dollar signs signifying rising asx share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Three ASX healthcare shares are making their shareholders very happy today, posting gains of 5%, 12% and 19% respectively in morning trade.

And this strong performance comes despite some broader healthcare sector headwinds on Thursday, which sees the S&P/ASX 200 Health Care Index (ASX: XHJ) down 0.4% at this same time.

So, which three ASX healthcare shares are bucking the trend and flying higher?

I'm glad you asked!

Three ASX healthcare shares leaping higher

The first company pleasing shareholders today is Immutep Ltd (ASX: IMM). Immutep shares are trading for 34.7 cents apiece, up 11.9%. That sees the ASX healthcare share up 22% in a year.

Investors are bidding up the clinical-stage biotechnology company following two positive drug trial announcements.

First Immutep reported on positive data from the Phase I trial evaluating its eftilagimod alpha (efti) in combination with KEYTRUDA (pembrolizumab) and chemotherapy for first-line treatment of metastatic non-squamous non-small cell lung cancer patients.

"The strength of these mature survival results coupled with a favourable safety profile in first-line treatment of patients with non-squamous NSCLC, the vast majority of whom have negative or low PD-L1 expression, is very encouraging," project lead Salah-Eddin Al-Batran said.

Immutep also reported on new data from a Phase II trial of efti in combination with radiotherapy plus pembrolizumab for patients with soft tissue sarcoma.

According to the release:

Based on preliminary analysis among 21 patients available for primary endpoint assessment, the triple combination therapy demonstrates significant efficacy in the neoadjuvant setting for resectable STS.

Which brings us to the second ASX healthcare share leaping higher today, Mesoblast Ltd (ASX: MSB).

Shares in the clinical-stage biotechnology company are up 18.7% today, trading for $1.81 each.

There's no fresh news out from Mesoblast since its quarterly update on 31 October. But the stock has been in a strong upward trend, with today marking the eighth consecutive trading day of gains. Mesoblast shares are now up an eye-popping 480% in 2024.

Which brings us to the third ASX healthcare share pleasing its investors on Thursday, pharmaceuticals company Neuren Pharmaceuticals Ltd (ASX: NEU).

Neuren shares have given back some of their early morning gains but remain up a healthy 4.9% at $17.35 each. Shares are up 22% over 12 months.

Investors are bidding up the Neuren share price today after the company announced its intention to commence an on-market share buyback program of up to $50 million. When a company buys back its shares on market, it tends to increase the value of the remaining shares.

Management stated:

Considering Neuren's sustainable and growing cash income from DAYBUE, the capital requirements for advancing NNZ-2591 and Neuren's current share price, the board has decided to deploy cash of up to $50 million to buy back shares

The ASX healthcare share's DAYBUE (trofinetide) product is approved by the US Food and Drug Administration (FDA) for the treatment of Rett syndrome in adult and paediatric patients two years of age and older.

Neuren's NNZ-2591 drug is in Phase 2 development for the treatment of multiple neurodevelopmental disorders.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

ResMed share price healthcare asx share price flat represented by doctor shrugging
Healthcare Shares

Will the CSL share price beat the market in 2025?

Let's see what analysts are predicting for this biotechnology giant next year.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Healthcare Shares

Which insider sold $770,000 worth of ResMed shares this week?

What's the situation?

Read more »

Senior woman using cpap machine to stop choking and snoring from obstructive sleep apnoea with bokeh and morning light background.
Healthcare Shares

Here's the outlook on ResMed shares in 2025

Can investors breath easy?

Read more »

businesswoman holds hand out to shake
Mergers & Acquisitions

Is this ASX All Ords stock primed for a takeover offer in 2025?

The ASX All Ords stock could draw the interest of global companies saddled with fading patents.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

2 ASX healthcare shares that are screaming buys in December

These might go on the Christmas list.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

2 ASX healthcare small-cap shares to buy now: brokers

These 2 small-cap healthcare companies have captured the attention of experts.

Read more »

Three rockets heading to space
Share Gainers

3 ASX biotech shares rocketing 10% to 26% on BIG news!

Investors are sending these three ASX biotech stocks flying higher on Thursday.

Read more »

A woman in her late 30s holds her hands out either side with the palms up as if indicating she doesn't know the answer to a question. She has a quizzical look on her face.
Healthcare Shares

What on Earth is happening with Mesoblast shares today?

First it was jumping and then it was sinking. What's going on?

Read more »